ScreenIT

Latest preprint reviews

1. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

   This article has 16 authors:

   1. Javier Perez-Saez
   2. María-Eugenia Zaballa
   3. Sabine Yerly
   4. Diego O. Andrey
   5. Benjamin Meyer
   6. Isabella Eckerle
   7. Jean-François Balavoine
   8. François Chappuis
   9. Didier Pittet
   10. Didier Trono
   11. Omar Kherad
   12. Nicolas Vuilleumier
   13. Laurent Kaiser
   14. Idris Guessous
   15. Silvia Stringhini
   16. Andrew S. Azman

   Reviewed by ScreenIT

2. Tracking cytosine depletion in SARS-CoV-2

   This article has 3 authors:

   1. Ruibang Luo
   2. Yat-Sing Wong
   3. Tak-Wah Lam

   Reviewed by ScreenIT

3. Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter

   This article has 18 authors:

   1. Jyothi Manohar
   2. Sajjad Abedian
   3. Rachel Martini
   4. Scott Kulm
   5. Mirella Salvatore
   6. Kaylee Ho
   7. Paul Christos
   8. Thomas Campion
   9. Julianne Imperato-McGinley
   10. Said Ibrahim
   11. Teresa H. Evering
   12. Erica Phillips
   13. Rulla Tamimi
   14. Vivian Bea
   15. Onyinye D. Balogun
   16. Andrea Sboner
   17. Olivier Elemento
   18. Melissa Boneta Davis

   Reviewed by ScreenIT

4. Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

   This article has 26 authors:

   1. J.J. Patten
   2. Patrick T. Keiser
   3. Deisy Gysi
   4. Giulia Menichetti
   5. Hiroyuki Mori
   6. Callie J. Donahue
   7. Xiao Gan
   8. Italo do Valle
   9. Kathleen Geoghegan-Barek
   10. Manu Anantpadma
   11. RuthMabel Boytz
   12. Jacob L. Berrigan
   13. Sarah Hulsey-Stubbs
   14. Tess Ayazika
   15. Colin O’Leary
   16. Sallieu Jalloh
   17. Florence Wagner
   18. Seyoum Ayehunie
   19. Stephen J. Elledge
   20. Deborah Anderson
   21. Joseph Loscalzo
   22. Marinka Zitnik
   23. Suryaram Gummuluru
   24. Mark N. Namchuk
   25. Albert-László Barabási
   26. Robert A. Davey

   Reviewed by ScreenIT

5. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

   This article has 34 authors:

   1. Jennifer Harcourt
   2. Azaibi Tamin
   3. Xiaoyan Lu
   4. Shifaq Kamili
   5. Senthil Kumar. Sakthivel
   6. Janna Murray
   7. Krista Queen
   8. Ying Tao
   9. Clinton R. Paden
   10. Jing Zhang
   11. Yan Li
   12. Anna Uehara
   13. Haibin Wang
   14. Cynthia Goldsmith
   15. Hannah A. Bullock
   16. Lijuan Wang
   17. Brett Whitaker
   18. Brian Lynch
   19. Rashi Gautam
   20. Craig Schindewolf
   21. Kumari G. Lokugamage
   22. Dionna Scharton
   23. Jessica A. Plante
   24. Divya Mirchandani
   25. Steven G. Widen
   26. Krishna Narayanan
   27. Shinji Makino
   28. Thomas G. Ksiazek
   29. Kenneth S. Plante
   30. Scott C. Weaver
   31. Stephen Lindstrom
   32. Suxiang Tong
   33. Vineet D. Menachery
   34. Natalie J. Thornburg

   Reviewed by ScreenIT

6. Tocilizumab Effect in COVID-19 Hospitalized Patients: A Systematic Review and Meta-Analysis of Randomized Control Trials

   This article has 10 authors:

   1. Basheer Abdulrahman
   2. Waleed Th Aletreby
   3. Ahmed F Mady
   4. Alfateh Mohammed Noor
   5. Mohammed Lhmdi
   6. Fahad Faqihi
   7. Abdulrahman M Alharthy
   8. Mohammed A Al-Odat
   9. Dimitrios Karakitsos
   10. Ziad A Memish

   Reviewed by ScreenIT

7. Female-male differences in COVID vaccine adverse events have precedence in seasonal flu shots: a potential link to sex-associated baseline gene expression patterns

   This article has 15 authors:

   1. AJ Venkatakrishnan
   2. Praveen Kumar-M
   3. Eli Silvert
   4. Enrique Garcia-Rivera
   5. Mariola Szenk
   6. Rohit Suratekar
   7. Patrick Lenehan
   8. Emily Lindemer
   9. John C. O’Horo
   10. Amy W. Williams
   11. Andrew D. Badley
   12. Abinash Virk
   13. Melanie D. Swift
   14. Gregory J. Gores
   15. Venky Soundararajan

   Reviewed by ScreenIT

8. When can we stop wearing masks? Agent-based modeling to identify when vaccine coverage makes nonpharmaceutical interventions for reducing SARS-CoV-2 infections redundant in indoor gatherings

   This article has 2 authors:

   1. Trevor S. Farthing
   2. Cristina Lanzas

   Reviewed by ScreenIT

9. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients

   This article has 12 authors:

   1. Florian Bieberich
   2. Rodrigo Vazquez-Lombardi
   3. Alexander Yermanos
   4. Roy A. Ehling
   5. Derek M. Mason
   6. Bastian Wagner
   7. Edo Kapetanovic
   8. Raphael Brisset Di Roberto
   9. Cédric R. Weber
   10. Miodrag Savic
   11. Fabian Rudolf
   12. Sai T. Reddy

   Reviewed by ScreenIT

10. Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants

    This article has 24 authors:

    1. Elizabeth Jaworski
    2. Rose M Langsjoen
    3. Brooke Mitchell
    4. Barbara Judy
    5. Patrick Newman
    6. Jessica A Plante
    7. Kenneth S Plante
    8. Aaron L Miller
    9. Yiyang Zhou
    10. Daniele Swetnam
    11. Stephanea Sotcheff
    12. Victoria Morris
    13. Nehad Saada
    14. Rafael RG Machado
    15. Allan McConnell
    16. Steven G Widen
    17. Jill Thompson
    18. Jianli Dong
    19. Ping Ren
    20. Rick B Pyles
    21. Thomas G Ksiazek
    22. Vineet D Menachery
    23. Scott C Weaver
    24. Andrew L Routh

    This article has been curated by 1 group:

    • Curated by eLife

      Evaluation Summary:

      The ability to fully resolve the whole genome of viral pathogens is often hampered by a multitude of different obstacles, one of which is optimally amplifying different regions of the genome. Part of this challenge lies in designing the best primers pairs that can consistently amplify PCR products despite the presence of changes (mutations) in the genome. The work described by Jaworski and colleagues can potentially provide an alternative approach that does not depend on primer pairs to fully sequence one such viral pathogen, SARS-CoV-2, and can also be applied towards other viral families.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife, ScreenIT